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Abstract
Members of the intersectin (ITSN) family of scaffold proteins consist of multiple modular domains, each with distinct ligand
preferences. Although ITSNs were initially implicated in the regulation of endocytosis, subsequent studies have revealed a
more complex role for these scaffold proteins in regulation of additional biochemical pathways. In this study, we performed
a high throughput yeast two-hybrid screen to identify additional pathways regulated by these scaffolds. Although several
known ITSN binding partners were identified, we isolated more than 100 new targets for the two mammalian ITSN proteins,
ITSN1 and ITSN2. We present the characterization of several of these new targets which implicate ITSNs in the regulation of
the Rab and Arf GTPase pathways as well as regulation of the disrupted in schizophrenia 1 (DISC1) interactome. In addition,
we demonstrate that ITSN proteins form homomeric and heteromeric complexes with each other revealing an added level
of complexity in the function of these evolutionarily conserved scaffolds.
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Introduction
The regulation of biochemical pathways is mediated in part
through numerous protein-protein interactions that are facilitated
by protein scaffolds. It has become widely accepted that protein
interactions are frequently mediated by modular protein
recognition domains with characteristic binding and functional
properties. For example, the Src homology 2 (SH2) domain
represents the prototypical modular domain responsible for
interaction with phosphotyrosine. Since the discovery of SH2
domains, a plethora of domains have been defined, each with
unique specificity for distinct types of ligands (reviewed in [1]).
The arrangement of these protein interaction domains results in
intricate interaction networks for a given protein.
Intersectin (ITSN) is a multi-domain scaffold protein. There
are two ITSN genes in mammals, ITSN1 and ITSN2, each
encoding a short and long isoform and sharing 59% identity and
greater than 70% similarity. Both ITSN short (ITSN-S) isoforms
possess two amino-terminal Eps15 homology (EH) domains
followed by a coiled-coil (CC) domain and five Src homology 3
(SH3) domains. The ITSN long isoform (ITSN-L) contains all
these domains in addition to an extended carboxy-terminus
encoding a Dbl homology (DH) domain, a Pleckstrin homology
(PH) domain, and a C2 domain. The DH and PH domains
function together as a guanine nucleotide exchange factor (GEF)
that regulates the activation of the Rho family GTPase Cdc42.
In addition to these major isoforms, there are numerous
additional splice variants for each ITSN, several of which have
altered interactions with specific targets [2,3].
The modular domains present in ITSN initially suggested a
role in endocytosis and indeed, ITSNs interact with numerous
components of the endocytic machinery to regulate the processes
of endocytosis [2]. However, ITSNs also associate with a number
of proteins involved in regulating signal transduction pathways
suggesting additional functions for these scaffold proteins [2].
Although a number of ITSN binding proteins have been
described, we sought to identify novel ITSN targets through
use of a high throughput yeast two-hybrid screen. The advantage
of our approach is that we used smaller fragments of ITSN
(,350aa) encompassing one or two individual domains of the
protein thereby allowing for identification of interacting proteins
specific to each of these modular domains. We have identified an
extensive array of binding proteins for both ITSN1 and ITSN2
and present an analysis of several novel ITSN targets. In addition
to identification of known pathways regulated by ITSNs, our
findings reveal a number of novel biochemical pathways
involving ITSNs.
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Materials and Methods
Cell lines and reagents
COS cells (kindly provided by Dr. John Cidlowski, NIH) [4]
and HEK 293T cells (kindly provided by Dr. Brian Howell, Fred
Hutchinson Cancer Center) [5] were maintained in Dulbecco’s
Modified Eagle Medium (DMEM) supplemented with 10% fetal
bovine serum. COS cells were transfected with Lipofectamine
(Invitrogen, Carlsbad, CA) as recommended by the manufacturer.
HEK293T cells were transfected with the calcium phosphate
procedure as described previously [6]. Antibodies used include
anti-hemagglutinin (HA) monoclonal (Covance, Emeryville, CA),
anti-FLAG monoclonal (Sigma, St. Louis, Missouri), anti-Rab5
monoclonal (Santa Cruz Biotechnology, Santa Cruz, CA), anti-
VSV (Sigma, St. Louis, Missouri), anti-EEA1 goat polyclonal
(Santa Cruz Biotechnology, Santa Cruz, CA), anti-ITSN1 rabbit
polyclonal [4], anti-MYC monoclonal (Sigma, St. Louis, Missouri).
Glutathione-Sepharose beads were purchased from GE Health-
care (Piscataway, NJ)
DNA Constructs
The BiFC vectors pFlag-VN-173N and pHA-VC155N were
gifts from Dr. Chang-Deng Hu (Purdue University, West
Lafayette, IN). The Rab5 constructs were gifts from Dr. Richard
Pagano (Mayo Clinic, Rochester, MN). DISC1 constructs were
gifts from Dr. Jill Morris (Northwestern University, Chicago, IL).
The human ITSN2 constructs were gifts from Susana de la Luna
(Center for Genomic Regulation, Barcelona, Spain). The Arf6 and
Arfaptin2 constructs were gifts from Dr. John Exton (Vanderbilt
University, TN). The PDE4D3 construct was a gift from Drs.
George Baillie and Kimberly Dodge-Kafka (University of
Glasgow, Glasgow, UK).
Yeast two-hybrid screens
Yeast two-hybrid (Y2H) analysis was performed through a
contract with Myriad Genetics essentially as described previously
[7] using the various individual domains of mouse or human ITSN
as bait. The various ITSN baits were used to screen multiple
cDNA libraries derived from human or mouse tissues as indicated
in Tables S1 and S2.
Bimolecular fluorescence complementation (BiFC) and
confocal imaging
BiFC was performed essentially as described [8]. Briefly,
expression constructs consisting of the amino-terminus or
carboxy-terminus of Venus (VN and VC, respectively) [9] were
fused to the amino-terminus of the respective proteins interest.
COS cells were transiently transfected late in the day and then
imaged the following morning so that the various proteins were
not vastly overexpressed. CFP was co-transfected with the BiFC
constructs, at a fivefold-lower concentration, to mark transfected
cells. Samples were then imaged by confocal analysis on a Zeiss
LSM 510 confocal microscope as described [4,8]. Note that cells
transfected with either VN– or VC– fusions alone were not
fluorescent due to lack of the corresponding complementary
fragment [8]. As a negative control, VN-fusion constructs were
co-transfected with VC-pep which expresses an 11 amino acid
peptide (TSRLPPLGVGN) fused to the carboxy-terminus of VC.
Immunofluorescent staining of cells
Cells were plated on glass bottom plates, fixed in 3.7%
formaldehyde, then permeabilized by incubation in blocking
buffer (1xPBS, 3% BSA, 0.1% Triton X-100) for 1 hr at RT.
Primary antibody was added for 2 hrs at room temperature, rinsed
Figure 1. Yeast two-hybrid (Y2H) analysis of ITSN scaffolds. A. ITSN baits. Shown are schematic representations of the long isoforms of ITSN1
and ITSN2 with the regions used in Y2H screening shown under each structure. Baits encompassing the DH-PH-C2 regions of ITSN2 were not
successful in screening. B. Targets of ITSN proteins identified by Y2H and the biological processes regulated by these targets. Those targets
characterized in this manuscript are underlined and italicized.
doi:10.1371/journal.pone.0036023.g001
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3 times with 1xPBS. Fluorescently tagged secondary antibody
(donkey anti-rabbit, anti-mouse, or anti-goat antibodies conjugat-
ed to either fluorescein isothiocyanate (FITC), tetramethylrhoda-
mine B isothiocyanate (TRITC), or Cy5; Jackson ImmunoR-
esearch, West Grove, PA) was added to samples for 1 hr at room
temperature followed by 3 rinses with 1xPBS. Samples were
imaged on a confocal microscope as described above.
GST pull down experiments
GST-ITSN1 fusion proteins were used to affinity purify specific
targets from cell lysates as previously described [10]. Briefly, GST-
ITSN1 encompasses the entire ITSN1-S coding region, GST-EH
encompasses both EH domains, GST-CC encompasses the coiled-
coil (CC) region, GST-EH-CC encompasses both EH domains
and the CC region, and GST-SH3 encompasses all five SH3
domains. HEK293T cells were transiently transfected with the
indicated expression constructs. Forty-eight hours after transfec-
tion, cells were washed with warm phosphate-buffered saline (PBS)
and lysed in PLC lysis buffer (50 mM HEPES, pH 7.5, 150 mM
NaCl, 10% glycerol, 1% Triton X-100, 1 mM EGTA, 1.5 mM
MgCl2, and 100 mM NaF) supplemented with protease inhibitors.
After 30 min at 4uC on a nutator, the soluble lysates were obtained
by centrifugation at 14,000 rpm for 10 min and used for the GST
pull-down assay. GST fusion proteins were purified from DH5a E.
coli using glutathione-sepharose beads. Equivalent amounts of
fusion proteins along with GST as a negative control were added
to equal amounts of cell lysates, incubated on a nutator at 4uC for
2 h. At the end of the incubation, beads were spun down, washed
three times with PLC lysis buffer (described above) and then
resuspended in LDS sample buffer (Invitrogen, Carlsbad, CA).
The samples were fractionated on a gel, transferred to an
Immobilon-P membrane, and probed with the indicated antibod-
ies. The blots were developed with SuperSignal chemilumines-
cence reagent (Pierce, Rockford, IL).
Results
Identification of ITSN targets by high throughput yeast
two-hybrid (Y2H) analysis
In an effort to define the biological targets of the ITSN scaffolds,
we subjected ITSN1 and ITSN2 to a high throughput Y2H
screen. To identify ligands of each ITSN domain, our approach
utilized ITSN bait fragments encoding subsets of the domains
present in ITSN and spanning the majority of the coding sequence
of both proteins (Figure 1A). Furthermore, we screened multiple
prey libraries generated from human brain, spleen, macrophage,
and skeletal muscle as well as mouse embryo. The ITSN binding
proteins identified in our screen are listed in Tables S1 and S2
with targets unique to this study highlighted in yellow. We
identified 55 binding proteins for ITSN1, 62 interactors for
ITSN2, and 10 targets common to both ITSNs. However, our
screen failed to isolate several validated targets of ITSNs
suggesting that our results underestimate the number of bona fide
ligands in vivo. For example, ITSN1 binds the E3 ubiquitin ligase
Cbl [4], which was identified as a target in the ITSN2 screen but
not in the ITSN1 screen (see Tables S1 and S2). The pool of ITSN
binding proteins highlights the pivotal role of ITSNs in
endocytosis, GTPase regulation, and receptor tyrosine kinase
(RTK) regulation (Figure 1B), and suggests that ITSNs may have
novel roles in regulating additional pathways as detailed in the
following sections.
ITSN-targets involved in endocytosis
Twenty-one proteins involved in endocytosis were identified as
potential ITSN binding proteins in our Y2H screens (Tables S1 and
S2) consistent with ITSNs’ known role in this process [2,11,12].
Several of these targets have previously been identified as ITSN
partners including dynamin II, Epsin2, Eps15, Eps15L, clathrin,
synaptojanin2b, amphiphysin, SNAP29, HIP1, Dab2, PACSIN3,
AP2, REPs, CIN85, and SH3GL1 (EEN) (reviewed in [2,11]).
However, a number of additional endocytic proteins were identified
as potential ITSN1 targets in our screen including CALM, KIF16B,
Alix, FNBP1, and Syntaxin4. These results further support the
involvement of ITSNs in regulating endocytosis [2].
Dimerization of ITSNs
ITSN1 was isolated as a binding partner for itself (Table S1)
suggesting that ITSN1, and potentially ITSN2, may form homo–
and heterodimers in vivo. Given that related EH-domain
containing protein Eps15 and its family member Eps15L form
tetramers [13,14], we tested whether ITSNs also formed
oligomeric complexes. Since initial attempts to co-precipitate
ITSNs tagged with different epitope tags (e.g., GFP and HA) were
not successful, we turned to using bimolecular fluorescence
complementation (BiFC) [15] to assess interactions. The advan-
tages of this technique are that it allows for visualization of protein-
protein interactions in live cells and does not require high
overexpression of proteins or elaborate post-processing of images
as seen with other techniques such as fluorescence resonant energy
transfer (FRET). ITSN1-S was fused to the carboxy-terminus of
amino acids 1–173 of Venus (VN) or amino acids 155–238 of
Venus (VC) [16]. Both VN-ITSN1-S and VC-ITSN1-S were co-
expressed in COS cells resulting in fluorescence complementation
demonstrating for the first time that ITSN1 forms oligomers
(Figure 2A). The intracellular distribution of the BiFC signal was
indistinguishable from that of YFP-ITSN1-S (Figure 2F) [10,17].
Given that ITSN1-L contains all the domains of ITSN1-S, we also
examined the ability of ITSN1-L to homodimerize and hetero-
dimerize with ITSN1-S. ITSN1-L formed homodimers (data not
shown) and also formed heterodimers with ITSN1-S (Figure 2B).
Given the conserved structures of ITSN1 and ITSN2 and the high
degree of sequence homology between these two proteins, we
tested whether ITSN2 homodimerized as well as heterodimerized
with ITSN1. Like ITSN1, ITSN2-S formed homomeric complex-
es (Figure 2C) as well as heteromeric complexes with ITSN1-S
(Figure 2D). No signal was observed upon co-expression of VN-
ITSN1-S with VC-pep, a non-specific peptide fused to VC as a
negative control (Figure 2E). These data indicate that ITSN1 and
ITSN2 isoforms form a variety of homo- and heterodimeric
complexes.
GTPase regulation
Previous studies demonstrated that ITSN1 regulates activation of
several members of the Ras superfamily including Ras [17,18],
Cdc42 [18,19,20], and potentially Rac [21]. Our Y2H screen
identified a number of regulators and effectors of multiple Ras family
GTPases including Ras, Rab, Arf, and Rho (Tables S1 and S2).
ITSN1 has previously been reported to bind Sos1, a Ras GEF,
leading to Ras activation [17,22,23]. In addition to reproducing
these findings, we isolated both Sos1 and Sos2 as ITSN2 binding
partners suggesting that both ITSN1 and ITSN2 participate in Ras
activation via their interaction with multiple Ras GEFs. Exchange
factors for additional Ras family members were also isolated in our
Y2H screen including TRIO (Rho GEF), P-REX1 (Rac GEF),
TIAM1 (Rac GEF), SWAP70 (Rac GEF), and PSCD1/cytohesin
(Arf GEF). In addition to GEFs, ITSNs interacted with several
Identification of Novel ITSN Targets
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GTPase activating proteins (GAPs) including the p85a subunit of
PI3Ks (Rab GAP) [24] and HRB/HRB-L (Arf GAPs). Although not
a GAP, PPFIA2 binds GIT1, a G-protein coupled receptor (GPCR)-
interacting ArfGAP [25]. Finally, ITSNs also interacted with a
number of effectors and targets of Ras superfamily GTPases
including Arfaptin2 (Arf and Rac), SCOCO (Arfs), GOLGA4
(Rabs), GolgB1 (Rabs), Rabaptin-5 (Rabs), KIF16B (Rabs), and
ERC1/CAST (Rabs). Both Arf and Rab play integral roles in
regulating vesicular trafficking providing a potential mechanistic
link with ITSNs’ established role in endocytosis and receptor
trafficking [4]. Thus, ITSNs’ ability to interact with multiple
Figure 2. ITSNs form homo and heterodimers. Bimolecular fluorescence complementation was used to assess the dimerization of ITSN1 and
ITSN2 isoforms in COS cells. A–E. The BiFC emission from the reconstituted Venus fluorophore was pseudocolored green (left panel). CFP
(pseudocolored red, right panel) was co-transfected to mark transfected cells and only CFP-positive cells were imaged BiFC. A. ITSN1-S forms
homodimers. VN-ITSN1-S was co-expressed with VC-ITSN1-S. B. The short and long isoforms of ITSN1 form heterodimers. VN-ITSN1-S was co-
expressed with VC-ITSN1-L. C. ITSN2-S forms homodimers. VN-ITSN2-S was co-expressed with VC-ITSN2-S. D. ITSN1 and ITSN2 heterodimerize. VN-
ITSN1-S was co-expressed with VN-ITSN2-S. E. As a negative control for BiFC, VN-ITSN1-S was co-expressed with a non-specific peptide fused to VC
(VC-pep). F. For comparison with the BiFC results, YFP-ITSN1-S was expressed in COS cells. Shown are two different panels of positive cells. The
fluorescence patterns shown in all panels (A–F) are representative of localization observed throughout the plate. These results are representative of at
least three independent experiments. Note: white scale bar represent 10? m.
doi:10.1371/journal.pone.0036023.g002
Figure 3. ITSN1 interacts with components of the Rab5 GTPase pathway. A. ITSN1 interacts with Rabaptin5. Endogenous ITSN1 (red) in HeLa
cells co-localizes with myc-tagged Rabaptin5 (green). Antibodies to Rabaptin5 did not detect the endogenous protein. Overlap of proteins is shown
in yellow. Regions of overlap were extracted from the image using ImageJ. B. Endogenous ITSN1 (green) co-localizes with endogenous Rab5 (red) in
COS cells. Overlap of proteins is shown in yellow. Regions of overlap were extracted from the image using ImageJ. C. ITSN1-S forms a complex with
Rab5 on early endosomes. HeLa cells were transfected with VN-Rab5 and VC-ITSN1-S and then stained with antibody to EEA-1 (red). The BiFC complex
of Rab5 and ITSN1-S is pseudocolored green. Overlap of the BiFC complex with EEA1 is shown in yellow. Regions of overlap were extracted from the
image using ImageJ. Note: white scale bars represent 20? m. The fluorescence patterns shown in all panels are representative of localization observed
throughout the plate.
doi:10.1371/journal.pone.0036023.g003
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regulators of the Arf and Rab pathways suggest an in vivo link of
ITSNs to regulation of these Ras family GTPase.
To confirm a subset of these interactions, we examined the
interaction of ITSN1 with components of the Rab and Arf
pathways (Figure 3). Endogenous ITSN1 co-localized with the
Rab-5 regulator, Rabaptin-5 (Figure 3A). Initial attempts to stain
for endogenous Rabaptin-5 were unsuccessful due to background
problems with available antibodies [26]. Given the involvement of
Rabaptin-5 in the regulation of Rab5 activation and function [26],
we examined whether ITSN1 interacted with Rab5. Endogenous
ITSN1 co-localized with endogenous Rab5 (Figure 3B). BiFC
analysis confirmed an interaction between these two proteins
(Figure 3C). Furthermore, the ITSN1-Rab5 complex localized
with early endosomal antigen 1 (EEA1) indicating that the ITSN1-
Rab5 complex was associated with early endosomes (Figure 3C).
In addition to identification of Rab pathway components, our
Y2H screen identified potential links between ITSN1 and multiple
components of the Arf pathway as noted above. To explore the
potential interaction of ITSN1 with the Arf pathway, we utilized
BiFC to examine interaction of ITSN1 with Arfaptin2, an effector
of Arf6 and Rac [27,28]. As shown in Figure 4A, ITSN1 associates
with Arf6 and its effector Arfaptin2. In addition, ITSN1, Arf6, and
Arfaptin2 co-localize on a subset of structures (Figure 4B) which
we presume represent intracellular vesicles given their punctate
appearance and similar morphology to EGFR and ITSN1 double
positive vesicles [17] as well ITSN1-Rab5 positive structures
(Figure 3). Finally, co-expression of Arfaptin2 with the full length
Figure 4. ITSN1 interacts with components of the Arf6 GTPase pathways. A. ITSN1 interacts with Arf6 as well as its effector Arfaptin2. BiFC
was used to analyze the interaction of ITSN1S with components of the Arf6 pathway. VN-ITSN1-S was co-expressed in COS cells with VC-Arf6 (top
panels), VC-Arfaptin2 (middle panels), or VC-pep (bottom panels) as a negative control. The emission from the reconstituted Venus fluorophore was
pseudocolored green. CFP (pseudocolored red) was co-transfected to mark transfected cells and only CFP-positive cells were imaged. Scale bar,
20 um. The fluorescence pattern shown in all panels are representative of localization observed throughout the plate. B. ITSN1 forms a trimolecular
complex with Arf6 and Arfaptin2 in COS cells. Top panels: VN-ITSN1-S and VC-Arf6 were co-expressed in the absence of CFP-Arfaptin2 to demonstrate
lack of bleed through of the BiFC signal into the CFP channel. Middle panels: CFP-Arfaptin2 was expressed alone to demonstrate lack of bleed
through of the CFP signal into the BiFC channel. Bottom panels: VN-ITSN1-S, VC-Arf6, and CFP-Arfaptin2 were co-expressed in COS cells. The BiFC
complex of VN-ITSN1-S and VC-Arf6 co-localizes with CFP-Arfaptin2. A region of overlap of the BiFC complex with CFP-Arf6 is enlarged in the inset in
the bottom right panel. Note: white scale bar represents 20? m. The fluorescence pattern shown in all panels are representative of localization
observed throughout the plate. C. VC-Arfaptin2 co-precipitates with ITSN1. HA-epitope tagged ITSN1-S or various domains of ITSN1 were co-
expressed with VN-Arfaptin2 which contains a FLAG epitope tag. HA-immunoprecipitates were probed for either HA (top panel) or FLAG (bottom) to
detect association of Arfaptin2. The CC region interacts most strongly with VN-Arfaptin2 consistent with the Y2H results (see Table S1).
doi:10.1371/journal.pone.0036023.g004
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ITSN1 or various truncation mutants indicates that Arfaptin2
interacts with ITSN1 through the EH domains and CC region
(Figure 4C). Although Arfaptin2 appears to bind more weakly to
the EH-CC fragment, this protein is expressed at lower levels.
Thus, it appears that Arfaptin2 interacts similarly with the CC and
EH-CC fragments suggesting that the CC region is the
predominant region for interaction consistent with our Y2H
results (see Table S1). These data indicate that ITSN1 is a
component of Arf GTPase regulated pathways.
ITSNs and receptor tyrosine kinase regulation
While the above interactions demonstrate a role for ITSNs in
GTPase regulated pathways in particular, our Y2H results reveal
additional links between ITSNs and regulators of signal transduc-
tion pathways (Tables S1 and S2). For example, ITSNs interacted
with both Cbl and phosphatidylinositol 3-kinase, specifically PI3K-
C2b (Tables S1 and S2). Indeed, ITSN1 regulates both of these
proteins [4,10]. However, our Y2H screens identified additional
components of RTK pathways as potential binding partners for
ITSNs. More specifically, we identified several regulators of the E3
ubiquitin ligase Cbl: Alix, Sprouty2 (Spry2) and CIN85.
Interestingly, CIN85 has been described as an ITSN1 target
[29] and we have recently demonstrated that Spry2 represents a
bona fide target of ITSN1 [30].
ITSNs and neurological disease
ITSN1 has been implicated in neurodegeneration through its link
with regulation of the JNK MAPK pathway and its association with
several proteins that interact with the protein product of the
Huntington’s Disease gene (reviewed in [2]). Furthermore, ITSN1
was identified as a binding partner for DISC1 (disrupted in
schizophrenia 1) [31] suggesting a potential role in psychiatric
disease as well [31]. Indeed, several of the identified ITSN1 and
ITSN2 targets interact with a DISC1 binding protein (e.g.,
PDE4DIP, ERC1, PPFIA2, and RUFY) (Figure 5A). Given
DISC1’s interaction with phosphodiesterase 4 [32], we tested
whether ITSN1 might also interact with this pathway. Co-
expression of VN-ITSN1-S with VC-PDE4D3 resulted in signifi-
cant BiFC signal whereas the VC-pep control was negative
(Figure 5B). To confirm this interaction, we further examined the
association of ITSN1 and PDE4D3 by co-immunoprecipitation.
PDE4D3 co-precipitates with FLAG-tagged ITSN1-S (VN-ITSN1-
S) but not with FLAG-tagged CFP (Figure 5C). Given this
association of ITSN1 with PDE4D3, we next tested whether ITSN1
might directly interact with DISC1. Examination of the DISC1
sequence indicates the presence of a Pro-rich sequence (aa 730–736;
PPIPPRL) that conforms to a consensus ITSN1 SH3 binding site
[10]. Using GST-tagged fusion proteins, we observed significant
binding of ITSN1’s SH3 domains to DISC1 (Figure 5D). However,
neither GST nor GST-EH interacted with DISC1 demonstrating
specificity in this interaction. Furthermore, we did not detect
significant binding of ITSN1 SH3 domains to the truncated DISC1
protein which lacks the consensus Pro-rich sequence. Together,
these data suggest that ITSN1 and possibly ITSN2, may coordinate
interaction of several proteins with the DISC1.
Additional functions
Membrane curvature. ITSNs bind FCHo proteins at sites
of nascent vesicle formation [33] suggesting a role for ITSNs in
regulating membrane curvature [2]. In further support of this
notion, we identified multiple ITSN binding partners involved in
membrane curvature including Arfaptin2 (Figure 4), FCHSD1 &
2, CALM, Epsin2a, HIP1, PACSIN3, FNBP1, endophilin,
amphiphysin, FNBP4, and PPFIA2 suggesting that ITSNs may
induce or maintain membrane curvature through interactions with
this class of proteins.
Inositol phosphate/phosphatidylinositol phosphate
metabolism. ITSN1 binds a novel class 2 phosphatidylinositol
3-kinase, PI3K-C2b, to regulate an AKT cell survival pathway in
neurons [10]. Additionally, our Y2H results reveal connections of
ITSNs with multiple proteins involved in regulating inositol/
phosphatidylinositol metabolism (Table 1). In addition to PI3K-
C2b, ITSNs bind the p85a regulatory subunit of class 1 PI3Ks,
Beclin-1, a target for Class 3 PI3K, and PIK3AP1, an adaptor
protein that links the B-cell receptor to the p85 subunit of Class 1
PI3Ks. These interactions suggest an involvement of ITSNs in
regulation of multiple classes of PI3Ks. The isolation of inositol
1,4,5 trisphosphate 3-kinase A (ITPKA) as an ITSN1 binding
protein suggests a role for ITSNs in production of inositol
phosphates as well. In addition to regulating kinases that produce
inositol or phosphatidylinositol products, ITSNs may also regulate
the dephosphorylation of these important signaling molecules.
ITSN1 interacts with two inositol 5-phosphatases, SHIP2 [34,35]
and synpaptojanin [36,37], the latter of which was identified in our
Y2H screen (Tables S1) and plays an important role in membrane
curvature and membrane dynamics through regulation of
PI(4,5)P2 levels [38]. Our results reveal an additional interaction
with the phosphatidylinositol 3-phosphatase, myotubularin
through the intermediate filament protein desmin (Table 1)
suggesting that ITSNs may regulate a dynamic network of
proteins controlling the flux of inositol phosphates at different
stages of endocytosis. Indeed, the ITSN1-SHIP2 interaction is
important for regulation of endosomal dynamics [34].
Discussion
Previous studies have utilized Y2H screens to identify ITSN
binding partners [39,40]. Although the number of isolated ITSN
targets in Stelzl et. al. was quite limited (six ITSN1 targets; three
ITSN2 targets)[39], Wang and colleagues [40] identified 60
putative targets of C. elegans ITSN1 in their Y2H screen, a number
of which overlap with our results (e.g., CIN85/Ruk, Alix, epsin,
Dab, dynamin and synaptojanin). In contrast to these previous
screens, we employed a high throughput approach using smaller
fragments of ITSNs (,350aa) encompassing one or two of the
individual domains of ITSNs. This approach allowed for the
identification of interacting proteins specific to each of the
modular domains present in ITSNs. Indeed, our screens identified
a total of 127 potential ITSN-binding proteins, with the majority
of these putative ITSN-binding proteins representing novel targets
for the ITSN scaffolds. Although we believe that our results
provide a more comprehensive list of targets for the ITSN
proteins, it is possible that some of these proteins may not interact
with full length ITSNs. Thus, additional work will be needed to
validate each of these new targets.
ITSNs are evolutionarily conserved scaffold proteins that were
initially implicated in regulating endocytosis based on their
domain homology with other EH-containing proteins involved
in this process [36,41,42]. Indeed, ITSNs interact with multiple
endocytic proteins [37,41,43,44] and alter endocytosis when
overexpressed in cells [41,45]. Furthermore, loss-of-function
mutations in ITSN1 lead to clear defects in endocytosis
[40,46,47,48,49]. These defects appear to be due to impaired
recruitment of endocytic proteins to sites of membrane curvature
induced by FCHo proteins [33]. Our Y2H experiments reveal that
ITSNs interact with numerous proteins involved in membrane
curvature including Arfaptin2 (Figure 4), FCHSD1 & 2, CALM,
Epsin2a, HIP1, PACSIN3, FNBP1, endophilin, amphiphysin,
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FNBP4, and PPFIA2. Thus, ITSNs may play a critical role in the
induction or maintenance of membrane curvature through
interaction with this class of proteins.
While ITSNs clearly play a role in the process of endocytosis,
accumulating studies demonstrate additional biochemical roles for
these scaffolds (reviewed in [2]). Consistent with these studies, our
Y2H results reveal potential new connections between ITSNs and
several cellular pathways including Rab and Arf GTPase
regulation, receptor tyrosine kinase regulation, and inositol
phosphate/phosphatidylinositol metabolism (Table 1). Although
these targets represent distinct biochemical pathways, there is also
clear overlap of these pathways with the endocytic pathway.
Indeed, endocytosis plays a critical role in regulation of many
RTKs [50]. Several of the ITSN-binding proteins we identified
(Alix, Spry2, CIN85) represent attractive ITSN targets that might
provide an explanation for our previous results that demonstrate
ITSN1 enhances Cbl activity toward ubiquitylating the EGFR [4].
Although the precise mechanism by which ITSN1 enhances Cbl
function remains ill-defined, ITSN1 might enhance the interaction
of Cbl with an activator or disrupt interaction of Cbl with an
inhibitor [4]. Indeed, Spry2 represents a bona fide target of ITSN1
that inhibits activation of Cbl. These results suggest that ITSN1
enhances Cbl activation by disrupting the interaction of Spry2
with Cbl [30].
Regulation of inositol phosphate/phosphatidylinositol metabo-
lism also has important implications for the endocytic pathway as
well [51]. In addition, ITSNs may also play a role in regulating
nuclear processes through the interaction with a diverse array of
nuclear proteins including RNA binding proteins and transcrip-
tion factors (Tables S1 and S2). Together, these results suggest that
Figure 5. ITSNs and DISC1 interact with common proteins. A. ITSN1 was identified as a binding partner for DISC1 by Y2H [31]. However, a
number of additional connections between ITSN1/2 and DISC1 were identified in our Y2H screen. Proteins shaded yellow were identified as ITSN1 or
2 binding partners by Y2H. PPFIA2 is a member of the liprina family of scaffolds (PPFIA1-4) which bind the LAR family of transmembrane protein
phosphatases and are known to form heteromeric complexes with each other [57]. Thus, ITSNs and DISC1 may interact through a heteromeric
complex of PPFIA2 and PPFIA4. PDE4 (red), a known DISC1 interacting protein, was examined for interaction with ITSN1. B. Interaction of ITSN1 with
phosphodiesterase 4D3 isoform. HEK293T cells grown on coverslips were transfected with VN-ITSN1-S and either VC-PDE4D3 or VC-pep as a negative
control. CFP was co-transfected to mark transfected cells and only CFP-positive cells were imaged. The fluorescence pattern shown is representative
of localization observed throughout the plate. Note: white scale bar represent 10? m. C. ITSN1-S and PDE4D3 interaction was confirmed by co-
immunoprecipitation. HEK293T cells were transfected with VSV-tagged PDE4D3 and either VN-ITSN1-S or CFP. ITSN1 and CFP were
immunoprecipitated with FLAG antibody and the specific co-immunoprecipitation of PDE4D3 was determined by Western blot analysis with
aVSV antibody. Input (bottom panel labeled ‘‘Cell lysate’’) shows the level of PDE4D3 was expressed equally in both cell lysates. Note that an empty
lane was between the CFP and VN-ITSN1-S samples on the gel. The weak signal for PDE4D3 in that lane resulted from overflow of the sample. The top
3 panels in C were from the same membrane which had been separated into the indicated size ranges and probed with the indicated antibodies. CFP
and VN-ITSN1-S each possess a FLAG epitope tag. Similar results were obtained from three independent experiments. D. ITSN1 SH3 domains bind
DISC1. HEK293T cells were transfected with V5-tagged full length DISC1 (DISC1 FL; aa 1–854) or a truncated DISC1 (DISC1-TR; aa 1–597)
corresponding to the deletion resulting from a translocation breakpoint that disrupts the DISC1 locus [58]. GST-SH3 (encoding all 5 SH3 domains) but
not GST or GST-EH (encoding both EH domains) pulls down DISC1-FL but not DISC 1-TR (top panels). Expression of DISC1 proteins in cell lysates is
shown in the Western blot of cell lysates with aV5 antibody (bottom panels). Input GST fusion proteins are indicated in the Coomassie-stained gel to
the far right.
doi:10.1371/journal.pone.0036023.g005
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ITSN scaffolds function as critical biochemical hubs within the cell
[52]. However, it is most likely that ITSNs function to fine-tune
various biochemical pathways rather than function as obligate
components. Indeed, loss-of-function mutations in ITSN in both
mouse and C. elegans are viable and result in very mild mutant
phenotypes with subtle defects in endocytosis [40,48,49].
Many of the published binding partners for ITSNs interact with
the same regions raising the question of how ITSN’s specifically
interact with each of these targets. For example, Cbl, Sos, PI3K-
C2b, WASP, and Numb all interact specifically, although not
exclusively, with the SH3A domain of ITSN1 [2]. Although, it is
not possible for each of these proteins to bind simultaneously to the
same domain on one molecule of ITSN due to steric constraints, it
may nevertheless be possible for ITSNs to interact with more than
one of these proteins at the same time through oligomerization of
ITSNs (Figure 2). For example, a different SH3A binding protein
may bind to each ITSN molecule in an oligomeric complex
thereby allowing for interaction with multiple targets. However,
this solution also increases the complexity of potential ITSN
complexes. The related protein Eps15 forms tetramers through its
coiled-coil region [14] and interacts with ITSNs through this same
region ([41] and Tables S1 and S2). Since ITSN1 has been
reported to have at least 24 splice variants [53] and ITSN2 has at
least 4 splice variants, if we assume that each of these isoforms has
the potential to form homo– or hetero-tetramers with each other
and Eps15/Eps15R, then the number of potential unique
tetrameric complexes that could be formed in the cell is 304 or
810,000, each with potentially distinct preferences for targets!
Thus, the challenge will be to define the nature and existence of
such complexes and the biochemical and physiological importance
of these complexes.
Our Y2H results reveal an added complexity in the biochemical
pathways regulated by ITSNs. While these scaffolds play an
important role in regulating endocytosis, our findings reveal a
diverse array of biochemical pathways that involve these highly
conserved, multi-domain scaffolds. Furthermore, these data reveal
potential ITSN-regulated networks that may implicate these
scaffoldings in physiological or pathological processes. Of
particular interest is the potential link between ITSNs and
neurological disorders. ITSN1 has been implicated in neurode-
generation (reviewed in [2]) and the identification of ITSN1 as a
binding partner for DISC1 (disrupted in schizophrenia 1) suggests
a potential role for ITSN1 in psychiatric disease as well [31].
Indeed, our results demonstrate that ITSN1 directly interacts with
DISC1 as well as a number of proteins that either directly or
indirectly interact with DISC1 (e.g., PDE4DIP, PPFIA2, RUFY,
and ERC1/CAST) (Figure 5). These findings are in agreement
with the recent proposal that clathrin-mediated endocytosis and
protein trafficking pathways may play important roles in the
pathophysiology of schizophrenia and bipolar disorder [54]. It is
also interesting to note that the interactomes of DISC1 and
huntingtin, the protein product of the Huntington’s Disease gene,
share significant overlap suggesting common modes of action for
these two proteins [55]. Although ITSN1 has been directly
implicated in aggregation of mutant huntingtin [56], a functional
link between DISC1 and huntingtin has not been defined
experimentally.
The Y2H screen performed by our lab highlights the complexity
of cell signaling mediated by ITSN. Understanding ITSN binding
partners provides insight into how ITSN is organizing intracellular
pathways. Further exploration of the ITSN binding partners
identified in this screen will aid in our understanding of cellular
function.
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